Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -404.31% | 0.00% | 124.18% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -61.34% | 0.00% | 123.47% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 182.03% | 0.00% | -41.55% | 0.00% |
| Change in Net Operating Assets | 0.00% | 113.42% | 0.00% | -252.04% | 0.00% |
| Cash from Operations | 0.00% | -96.11% | 0.00% | 51.92% | 0.00% |
| Capital Expenditure | 0.00% | 27.98% | 0.00% | -309.62% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -221.25% | 0.00% | -68.75% | 0.00% |
| Cash from Investing | 0.00% | -228.11% | 0.00% | -69.98% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 200.00% | 0.00% | -202.78% | 0.00% |
| Issuance of Common Stock | 0.00% | 22.55% | 0.00% | 343.48% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 693.48% | 0.00% | -127.54% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -461.11% | 0.00% | 74.72% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -858.29% | 0.00% | -82.72% | 0.00% |